Hemerion Therapeutics
PrivateLast Round
Series A
May 22, 2025
Est. Valuation
$32.94M
Total Funding Raised
$29.21M
Company Overview
Hemerion Therapeutics is a biotechnology company that develops therapeutic solutions combining photosensitizing molecules and laser light technologies to treat resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemerion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hemerion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 22, 2025 | ||||
| Series A | Mar 31, 2025 | ||||
| Series A | Mar 1, 2025 | ||||
| Grant | Apr 14, 2023 | ||||
| Seed | Apr 14, 2022 | ||||
Seed | Jun 1, 2021 |
Key People
Founding team and executive leadership
Hemerion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Series A, Seed |
| European Regional Development Fund | Series A |
| FIRA Nord-Est 2 | Series A |
| Finorpa | Series A, Seed |
| Siparex Group | Series A |
| Finovam Gestion | Series A, Seed |
| Bpifrance | Series A, Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2025
$7M round completed.
- Apr 14, 2023
$2.16M grant received from Bpifrance.
Hemerion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemerion Therapeutics's valuation, stock price, and market status.